Androgen Pattern in Patients With Type 2 Diabetes-associated Erectile Dysfunction: Impact of Metabolic Control

Urology

Volumn 74, Issue 3, 2009, Pages 552-559

  El Sakka, Ahmed I ^a   Sayed, Hisham M ^b   Tayeb, Khaled A ^c  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c AL NOOR SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; METFORMIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LABORATORY TEST; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE;

ADULT; AGED; DEHYDROEPIANDROSTERONE SULFATE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; HUMANS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 69249212249     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.077     Document Type: Article

References (30)

1. Bhasin S., Cunningham G.R., Hayes F.J., et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91 (2006) 1995-2010
2. Harris M.I., Hadden W.C., Knowler W.C., et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes 36 (1987) 523-534
3. Harman S.M., Metter E.J., Tobin J.D., et al. Baltimore longitudinal study of aging: longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86 (2001) 724-731
4. Dhindsa S., Prabhakar S., Sethi M., et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 5462-5468
5. Bruning J.C., Gautam D., Burks D.J., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
6. Dandona P., Dhindsa S., Chaudhuri A., et al. Hypogonadotrophic hypogonadism in type 2 diabetes. Aging Male 11 (2008) 107-117
7. Luboshitzky R., Lavie L., Shen-Orr Z., et al. Pituitary-gonadal function in men with obstructive sleep apnea. The effect of continuous positive airways pressure treatment. Neuro Endocrinol Lett 24 (2003) 463-467
8. Boyanov M.A., Boneva Z., and Christov V.G. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6 (2003) 1-7
9. Kapoor D., Goodwin E., Channer K.S., et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154 (2006) 899-906
10. Corona G., Mannucci E., Fisher A.D., et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 5 (2008) 2454-2463
11. El-Sakka A.I., Sayed H.M., and Tayeb K.A. Diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl 31 (2008) 602-608
12. Rosen R.C., Riley A., Wagner G., et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
13. Rendell M.S., Rajfer J., Wicker P.A., et al., Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 281 (1999) 421-426
14. Crude and age-adjusted percentage of civilian, noninstitutionalized population with diagnosed diabetes, United States, 1980-2006; Data Source. Centers for Disease Control and Prevention, National Center for Health Statistics. http://www.cdc.gov/diabetes/statistics/prev/national/figage.htm.
15. Defay R., Papoz L., Barny S., et al. Hormonal status and NIDDM in the European and Melanesian populations of New Caledonia: a case-control study. Int J Obes Relat Metab Disord 22 (1998) 927-934
16. Oh J.Y., Barrett-Connor E., Wedick N.M., et al. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25 (2002) 55-60
17. Fukui M., Soh J., Tanaka M., et al. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J 54 (2007) 871-877
18. Carosa E., Martini P., Brandetti F., et al. Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf) 61 (2004) 382-386
19. Corona G., Mannucci E., Petrone L., et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 18 (2006) 190-197
20. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87 (2002) 589-598
21. Tsai E.C., Matsumoto A.M., Fujimoto W.Y., et al. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27 (2004) 861-868
22. Pitteloud N., Mootha V.K., Dwyer A.A., et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28 (2005) 1636-1642
23. Bhatia V., Chaudhuri A., Tomar R., et al. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 29 (2006) 2289-2294
24. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. Barrett-Connor E., Khaw K.T., and Yen S.S. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132 (1990) 895-901
26. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151 (1994) 54-61
27. Tannenbaum C., Barrett-Connor E., Laughlin G.A., et al. Longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the rancho bernardo study. Eur J Endocrinol 15 (2004) 717-725
28. Reiter W.J., Pycha A., Schatzl G., et al. Dehydroepiandrosterone in the treatment of erective dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 53 (1999) 590-594
29. El-Sakka A.I., Hassoba H.M., Sayed H.M., et al. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med 2 (2005) 551-558
30. El-Sakka A.I., and Hassoba H.M. Age-related testosterone depletion in patients with erectile dysfunction. J Urol 176 (2006) 2589-2593